α-Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in . Sierra JC, Suarez G, Piazuelo MB, Luis PB, Baker DR, Romero-Gallo J, Barry DP, Schneider C, Morgan DR, Peek RM, Gobert AP, Wilson KT (2019) Proc Natl Acad Sci U S A 116: 5077-5085 Inhibition of human gastric adenocarcinoma xenograft growth in nude mice by alpha-difluoromethylornithine. Upp JR, Beauchamp RD, Townsend CM, Barranco SC, Singh P, Rajaraman S, James E, Thompson JC (1988) Cancer Res 48: 3265-9 Effects of alpha-difluoromethylornithine and 5-fluorouracil on the proliferation of a human colon adenocarcinoma cell line. Kingsnorth AN, Russell WE, McCann PP, Diekema KA, Malt RA (1983) Cancer Res 43: 4035-8 Protective role of arginase in a mouse model of colitis. Gobert AP, Cheng Y, Akhtar M, Mersey BD, Blumberg DR, Cross RK, Chaturvedi R, Drachenberg CB, Boucher JL, Hacker A, Casero RA, Wilson KT (2004) J Immunol 173: 2109-17 Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. Barry DP, Asim M, Leiman DA, de Sablet T, Singh K, Casero RA, Chaturvedi R, Wilson KT (2011) PLoS One 6: e17510 Preventing Gastric Cancer Development by Inhibiting the Virulence of H. pylori Infection. Wilson KT (2019) Oncology (Williston Park) 33: 227-31
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.